Inflammation response of epithelial mucosa to chemo-radiotherapy cytotoxic effects leads to
mucositis, a painful side effect of antineoplastic treatments. About 40% of the patients treated …

Oral mucositis (OM) is a common, highly symptomatic complication of cancer therapy that
affects patients' function, quality of life, and ability to tolerate treatment. In certain patients …

Despite the enthusiasm surrounding novel targeted agents and immunotherapies,
chemotherapy remains the mainstay treatment for most human malignancies, either alone or …

Cancer, a major world public health problem, is associated with chemotherapy treatments
whose administration leads to secondary concerns, such as oral mucositis (OM). The OM …

Malnutrition and muscle wasting are frequently reported in cancer patients, either linked to
the tumor itself or caused by oncologic therapies. Understanding the value of nutritional care …

Abstract Purpose The Palliative Care Study Group in conjunction with the Oral Care Study
Group of the Multinational Association for Supportive Care in Cancer (MASCC) formed a sub …

Acute radiation dermatitis (ARD) commonly develops in cancer patients undergoing
radiotherapy and is often characterized by erythema, desquamation, and pain. A systematic …

Background Chemotherapy generally causes serious diarrhea and oral mucositis in cancer
patients, and subsequently affects treatment. Oral administration of probiotics provides a …

Oral mucositis is a common adverse effect of cancer therapy. Probiotics have been shown to
exert anti-inflammatory and immunomodulatory effects. We performed a meta-analysis of …

Oral mucositis (OM) is a common and impactful toxicity of standard cancer therapy, affecting
up to 80% of patients. Its aetiology centres on the initial destruction of epithelial cells and the …